Pages that link to "Q80821845"

The following pages link to Description of pharmacist interventions during physician-pharmacist co-management of hypertension (Q80821845):

Displaying 31 items.

• Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones (Q28076153) (← links)
• Effect of self-efficacy and social support on adherence to antihypertensive drugs (Q33814102) (← links)
• Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention (Q33899634) (← links)
• Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care. (Q33981333) (← links)
• Sustained blood pressure control following discontinuation of a pharmacist intervention (Q34019198) (← links)
• A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control (Q34099413) (← links)
• Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures (Q34356414) (← links)
• Team-based care and improved blood pressure control: a community guide systematic review (Q35189022) (← links)
• The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy (Q35671360) (← links)
• Pharmacist intervention for blood pressure control: medication intensification and adherence. (Q35868070) (← links)
• Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge (Q36053099) (← links)
• Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. (Q36201114) (← links)
• Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control (Q36277670) (← links)
• Evolution of Clinical Pharmacy in the USA and Future Directions for Patient Care (Q36767799) (← links)
• Evaluation of Prescriber Responses to Pharmacist Recommendations Communicated by Fax in a Medication Therapy Management Program (MTMP) (Q37237614) (← links)
• Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives (Q37318113) (← links)
• Reduction in adverse symptoms as blood pressure becomes controlled (Q37400346) (← links)
• The impact of pharmaceutical care on patients with hypertension and their pharmacists. (Q37672532) (← links)
• Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis. (Q37831764) (← links)
• A review of pharmacist recommendations in an aged care facility (Q37880309) (← links)
• Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients (Q37895071) (← links)
• Implementation of a hypertension clinic using a streamlined treatment algorithm (Q37999628) (← links)
• The impact of medication therapy management in older oncology patients (Q45077543) (← links)
• Pharmacist integration into the medical home: Qualitative analysis (Q45400100) (← links)
• Impact of Pharmacists in a Community-Based Home Care Service: A Pilot Program. (Q47212604) (← links)
• Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing (Q47428539) (← links)
• Instrumental variable methods to assess quality of care the marginal effects of process-of-care on blood pressure change and treatment costs (Q49748457) (← links)
• Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease (Q50056816) (← links)
• Patient-centered medical home: developing, expanding, and sustaining a role for pharmacists (Q50246279) (← links)
• Integration of pharmacists into team-based ambulatory care practice models. (Q53542580) (← links)
• Nurse Practitioner-Physician Comanagement: A Theoretical Model to Alleviate Primary Care Strain (Q88669708) (← links)